Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Stephen Proctor.

Newcastle AuthorsTitleYearFull text
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Anne Lennard
Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients2014
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Paul Milne
et al.
Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients2013
Professor Stephen Proctor
Dr Jennifer Wilkinson
Gillian Watson
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al.
Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study2012
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Helen Lucraft
Dr Richard McNally
Dr Tryfonia Mainou-Fowler
et al.
Comparative clinical responses of three chemotherapy schedules (VEPEMB, ABVD, CLVPP) in 175 Hodgkin Lymphoma patients over 60ys evaluated as part of the Shield (Hodgkin elderly) Study2011
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.
A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Professor Stephen Proctor
Dr Brian Angus
Dr Stephen Crosier
Dr John Anderson
et al.
A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.
A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Professor Anthony Moorman
Dr Lucy Chilton
Dr Jennifer Wilkinson
Hannah Ensor
Dr Nicholas Bown
et al.
A population-based cytogenetic study of adults with acute lymphoblastic leukemia2010
Professor Anthony Moorman
Dr Lucy Chilton
Dr Jennifer Wilkinson
Hannah Ensor
Natalie Bown
et al.
Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England Response2010
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation2010
Dr Rachel Crossland
Professor Stephen Proctor
Professor James Allan
Mature MicroRNAs Mir 18, 19a, 19b, 17 5p and 92 of the Mir 17 92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia2010
Dr Rachel Crossland
Professor Stephen Proctor
Professor James Allan
Dr Tryfonia Mainou-Fowler
Mature MicroRNAs Mir-18,-19a,-19b,-17-5p and-92 of the Mir-17-92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia2010
Professor Stephen Proctor
Dr Anne Lennard
Professor Graham Jackson
Dr Jennifer Wilkinson
Dr Michal Sieniawski
et al.
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control2010
Dr Michal Sieniawski
Dr Malcolm Farrow
Elaine Zhao
Dr Jennifer Wilkinson
Dr Tryfonia Mainou-Fowler
et al.
A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction Of Outcome2009
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens2009
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Michal Sieniawski
Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future2009
Dr John Anderson
Lynne Overman
Dr Katrina Wood
Professor Stephen Proctor
Dr Stephen Crosier
et al.
Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics2009
Dr Michal Sieniawski
Dr Jennifer Wilkinson
Professor Stephen Proctor
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone -Rituximab refractory patients2009
Richard Feltbower
Dr Richard McNally
Professor Stephen Proctor
Professor Roderick Skinner
Professor Hermann Josef Vormoor
et al.
The epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-20022009
Dr Tryfonia Mainou-Fowler
Lynne Overman
Dr Katrina Wood
Dr Brian Angus
Professor Stephen Proctor
et al.
A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-22008
Dr Tryfonia Mainou-Fowler
Professor Stephen Proctor
Dr John Anderson
CD31 density is a new risk factor for patients with B-cell chronic lymphocytic leukaemia2008
Dr Tryfonia Mainou-Fowler
Dr John Anderson
Professor Stephen Proctor
CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia2008
Dr Michal Sieniawski
Dr Jennifer Wilkinson
Dr Anne Lennard
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al.
Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.2008
Professor Stephen Proctor
Dr Jennifer Wilkinson
Hodgkin's lymphoma in the elderly: current status and future directions2008
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Sequential Evaluation of Outcome in Enteropathy Associated T Cell Lymphoma Comparing Standard Therapeutic Approaches - Surgery or CHOP-Like Chemotherapy with a New High Dose Ifosfamide/Methotrexate and Autologous Stem Cell Transplant Regimen: A Prospective Study of Scotland and Newcastle Lymphoma Group2008
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Tryfonia Mainou-Fowler
Dr Michal Sieniawski
Dr Katrina Wood
et al.
SHIELD - Study of Hodgkin lymphoma in the elderly/lymphoma data base: Progress report2008
Professor Stephen Proctor
Professor Anne Dickinson
The Effect of Cryopreservation on Umbilical Cord Blood Endothelial Progenitor Cell Differentiation2008
Dr Michal Sieniawski
Dr Tryfonia Mainou-Fowler
Dr Jennifer Wilkinson
Dr John Davison
Professor Graham Jackson
et al.
The effect of Diffuse Large B-Cell Lymphoma (DLBCL) treatment regimens on survival: a prospective cohort study [Poster]2008
Dr Tryfonia Mainou-Fowler
Lynne Overman
Dr Katrina Wood
Dr Stephen Crosier
Dr Brian Angus
et al.
A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-22007
Professor Stephen Proctor
Dr Jennifer Wilkinson
A web-based study concept designed to progress clinical research for 'orphan' disease areas in haematological oncology in the elderly: The SHIELD programme2007
Dr Penelope Taylor
Dr Kevin Windebank
Dr Helen Lucraft
Dr Katrina Wood
Dr Brian Angus
et al.
Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents2007
Dr Tryfonia Mainou-Fowler
Professor Stephen Proctor
CD31 density is inversely related to CD38 expression and predicts for disease outcome in patients with B-cell chronic lymphocytic leukaemia (B-CLL)2006
Dr Tryfonia Mainou-Fowler
Jean Norden
Dr Peter Middleton
Professor Stephen Proctor
Professor Anne Dickinson
et al.
CD31 expression and gene polymorphisms in patients with B-cell chronic lymphocytic leukemia (B-CLL)2006
Professor Stephen Proctor
Dr Jennifer Wilkinson
Current status of anti-CD30 monoclonal antibody therapy in anaplastic lymphoma and Hodgkin's lymphoma2006
Professor Stephen Proctor
Dr Jennifer Wilkinson
Extreme Hodgkin's lymphoma: Current problem areas2006
Professor Stephen Proctor
Improving the treatment of Hodgkin lymphoma in older patients2006
Dr Tryfonia Mainou-Fowler
Dr Brian Angus
Professor Stephen Proctor
Dr Penelope Taylor
Dr Katrina Wood
et al.
Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL)2006
Professor Anthony Moorman
Professor Stephen Proctor
Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia2006
Dr Penelope Taylor
Dr Brian Angus
Professor Graham Jackson
Dr Helen Lucraft
Professor Stephen Proctor
et al.
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial2006
Professor Stephen Proctor
The cost-effectiveness of rituximab, cyclophosphamide, vincristine and prednisolone (RCVP) compared with CVP for the treatment of follicular non-Hodgkin's lymphoma (NHL) in the UK2006
Professor Stephen Proctor
An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme2005
Professor Stephen Proctor
Cost-effectiveness analysis of rituximab combined with CHOP for treatment of diffuse large B-cell lymphoma2005
Professor Stephen Proctor
Dr Brian Angus
Dr Katrina Wood
Dr Tryfonia Mainou-Fowler
Microvessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PDEGF) in classical Hodgkin lymphoma (HL)2005
Professor Stephen Proctor
SGN-30 (Anti-CD30 monoclonal antibody) is active and well tolerated in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL)2005
Dr John Anderson
Dr Stephen Crosier
Lynne Overman
Dr Tryfonia Mainou-Fowler
Dr Sarah Fordham
et al.
Survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker2005
Professor Stephen Proctor
The antecedents of middle managers' strategic contribution: The case of a professional bureaucracy2005
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Helen Lucraft
Dr Penelope Taylor
Dr Katrina Wood
et al.
[abstract] International study of Hodgkin's lymphoma in the elderly2004
Dr Richard Fisher
Professor Stephen Proctor
Follicular Lymphoma International Prognostic Index2004
Professor Stephen Proctor
High dose chlorambucil in the treatment of lymphoid malignancies2004
Dr Tryfonia Mainou-Fowler
Professor Stephen Proctor
Dr Penelope Taylor
Interleukin 4 production by peripheral blood lymphocytes in patients with classical Hodgkin lymphoma2004
Dr Penelope Taylor
Professor Stephen Proctor
Lymphoma presenting as a parotid tumour: a population-based study of diagnosis, treatment and outcome on behalf of the Scotland and Newcastle Lymphoma Group2004
Professor Robert Taylor
Anna Lewall
Professor Stephen Proctor
Dr Peter Middleton
Emeritus Professor Doug Turnbull
et al.
Mitochondrial DNA mutations in the haematopoietic system.2004
Dr Katrina Wood
Dr Penelope Taylor
Professor Stephen Proctor
Survival in young patients (less than 40 years) with follicular lymphoma: a population based study by the Scotland and Newcastle Lymphoma Group.2004
Dr Tryfonia Mainou-Fowler
Professor Stephen Proctor
The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL)2004
Dr Annette Neylon
Dr Peter Saunders
Professor Stephen Proctor
Dr Penelope Taylor
Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients2003
Dr Stephen Crosier
Dr Katrina Wood
Dr Philip Taylor
Professor Stephen Proctor
Dr Brian Angus
et al.
IAP survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker2003
Dr Tryfonia Mainou-Fowler
Dr Penelope Taylor
Professor Anne Dickinson
Professor Stephen Proctor
Intracellular cytokine profiles by peripheral blood CD3(+) T-cells in patients with classical Hodgkin lymphoma2003
Professor Anthony Moorman
Dr Nicholas Bown
Dr Penelope Taylor
Professor Stephen Proctor
Population-based study of unselected acute myeloid leukemia cases reveals distinct cytogenetic pathways analogous to therapy-related AML/MDS2003
Anna Lewall
Dr Liewi Luo
Professor Stephen Proctor
Dr Peter Middleton
Professor Robert Taylor
et al.
Somatic mitochondrial DNA mutations in adult-onset leukaemia2003
Professor Stephen Proctor
Professor Graham Jackson
Dr Anne Lennard
Dr Brian Angus
Dr Katrina Wood
et al.
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)2003
Dr Gail Stark
Professor Anne Dickinson
Professor Graham Jackson
Dr Penelope Taylor
Professor Stephen Proctor
et al.
Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation2003
Professor Stephen Proctor
Dr Brian Angus
Professor Graham Jackson
Dr Anne Lennard
Dr Penelope Taylor
et al.
A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)2002
Dr Mark Velangi
Dr Michael Reid
Dr Nicholas Bown
Professor Graham Jackson
Professor Stephen Proctor
et al.
Acute lymphoblastic leukaemia of the L3 subtype in adults in the Northern health region of England 1983-992002
Dr Penelope Taylor
Professor Stephen Proctor
High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma2002
Dr Gail Stark
Dr Katrina Wood
Dr Fergus Jack
Dr Brian Angus
Professor Stephen Proctor
et al.
Hodgkin's disease in the elderly: a population-based study2002
Professor Stephen Proctor
The use of population based research approaches in haematological malignancy: a generic medical research tool2002
Professor Stephen Proctor
Dr Penelope Taylor

Age cohort subgroups in adult acute myeloid leukaemia studies: the population perspective

2001
Ilkay Celik
Professor Stephen Proctor
Fludarabine for chronic lymphocytic leukemia2001
Professor Stephen Proctor
High dose chlorambucil for the treatment of chronic lymphocytic leukaemia (cll) and low grade non-hodgkin's lymphoma (LG-NHL)2001
Professor Graham Jackson
Professor Stephen Proctor
Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant2001
Dr Katrina Wood
Dr Penelope Taylor
Professor Stephen Proctor
Pathological pitfalls in the diagnosis of follicular lymphoma in young people2001
Dr Tryfonia Mainou-Fowler
Dr Penelope Taylor
Professor Anne Dickinson
Dr Peter Saunders
Professor Stephen Proctor
et al.
Quantification improves the prognostic value of CD38 expression in B cell chronic lymphocytic leukaemia (BCLL)2001
Professor Stephen Proctor
Professor Anne Dickinson
Umbilical cord blood banks in the UK: have proved their worth and now deserve a firmer foundation2001
Professor Julie Irving
Dr Anne Lennard
Professor Stephen Proctor
Dr Penelope Taylor
Validation of the Hasford score in a demographic study in chronic granulocytic leukaemia2001
Dr Penelope Taylor
Professor Stephen Proctor
A population based study of lymphoma of the parotid gland2000
Professor Stephen Proctor
Dr Penelope Taylor
A practical guide to continuous population-based data collection (PACE): a process facilitating uniformity of care and research into practice2000
Dr Annette Neylon
Professor Stephen Proctor
Dr Peter Saunders
Dr Penelope Taylor
Clinically significant acute thrombocytopenic purpura in adults: The Northern Region experience2000
Professor Stephen Proctor
Formation of the Northern UK Leukaemia Consortium2000
Dr Brian Angus
Dr Fergus Jack
Professor Graham Jackson
Professor Stephen Proctor
Dr Penelope Taylor
et al.
Improved estimation of tumour burden leads to better prognostic discrimination in classical hodgkin's disease in adults2000
Dr Peter Middleton
Jean Norden
Diana Levett
Dr Mark Levasseur
Professor Julie Irving
et al.
Population-based study of the pattern of molecular markers of minimal residual disease in childhood and adult acute lymphoblastic leukemia: An assessment of the practical difficulty of representative sampling for trial purposes2000
Dr Penelope Taylor
Professor Stephen Proctor
Patterns of care and survival for adolescents and young adults with acute leukaemia - a population-based study1999
Professor Anne Dickinson
Professor Graham Jackson
Dr Penelope Taylor
Professor Stephen Proctor
Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants - effect of GVHD prophylaxis1999
Professor Stephen Proctor
A prognostic score for advanced Hodgkin's disease1998
Professor Stephen Proctor
Dr Penelope Taylor
Dr Brian Angus
A prospective evaluation of the use of a numerical prognostic index for patient management in the context of a population-adjusted clinical epidemiology (PACE) study in the Northern Region, UK1998
Professor Stephen Proctor
A strong expression of CD44-6v correlates with shorter survival in acute myeloid leukemia1998
Professor Stephen Proctor
A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia1998
Dr Tryfonia Mainou-Fowler
Professor Stephen Proctor
Professor Anne Dickinson
Apoptotic activity of gamma linolenic acid (GLA) on normal and malignant cells in B cell chronic lymphocytic leukaemia (BCLL)1998
Dr Xiao Wang
Professor Stephen Proctor
Professor Anne Dickinson
Cellular alloreactivity of human cord blood cells detected by T-cell frequency analysis and a human skin explant model1998
Dr Peter Middleton
Dr Penelope Taylor
Professor Graham Jackson
Professor Stephen Proctor
Professor Anne Dickinson
et al.
Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants1998
Dr Katrina Wood
Dr Keith Mitchell
Professor Stephen Proctor
Dr Fergus Jack
Helen Bell
et al.
Development of new monoclonal antibodies recognising CD5, CD10, CD23, cyclin D1 and Ki67 in paraffin sections, and determination of their value in diagnosis of small B cell lymphoma1998
Professor Graham Jackson
Dr Penelope Taylor
Dr Anne Lennard
Professor Anne Dickinson
Dr Peter Hamilton
et al.
Single centre experience of allogeneic bone marrow transplantation with GvHD prophylaxis based on cyclosporin alone: March 1983 June 19971998
Professor Graham Jackson
Dr Philip Taylor
Dr David Goff
Dr Anne Lennard
Dr Brian Angus
et al.
High dose ifosfamide in combination with etoposide and epirubicin in the treatment of relapsed/refactory Hodgkin's disease: A report on toxicity and efficacy.1997
Dr Fergus Jack
Professor Stephen Proctor
Identification of poor-risk patients under 55 years old with Hodgkin's disease at diagnosis - a neural approach1997
Professor Graham Jackson
Dr Penelope Taylor
Dr Peter Hamilton
Professor Stephen Proctor
The use of an all oral chemotherapy (idarubicin and etoposide) in the treatment of acute myeloid leukaemia in the elderly: a report of toxicity and efficacy1997
Dr Adrian Frank
Professor Stephen Proctor
Dr Michael Tilby
Detection and quantification of melphalan-DNA adducts at the single cell level in hematopoietic tumor cells1996
Professor Anne Dickinson
Professor Stephen Proctor
Emerita Professor Jane Calvert
Effects of interferon-α therapy on immune parameters in immune thrombocytopenic purpura1996
Dr Mark Levasseur
Dr Peter Middleton
Dr Brian Angus
Professor Stephen Proctor
Jean Norden
et al.

c-MYC gene abnormalities in high grade and centroblastic-centrocytic Non-Hodgkins Lymphoma

1995
Dr Michael Reid
Elizabeth Matheson
Dr Penelope Taylor
Professor Stephen Proctor
Emeritus Professor Andy Hall
et al.

Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia

1995
Professor Stephen Proctor
Dr Penelope Taylor
Dr Peter Carey
Dr Peter Hamilton
Dr Michael Reid
et al.

Evaluation of the impact of allogeneic transplant in first remission on an unselected population of patients with acute myeloid leukaemia aged 15-55 years

1995
Professor Stephen Proctor

The hyperstethoscope syndrome

1995
Professor Stephen Proctor
Dr Michael Reid

Virus infection-associated improvement of platelet counts in chronic ITP

1995
Professor Julie Irving
Professor Stephen Proctor
Professor Graham Jackson
Basophilia, t(15;17) translocation and atypical AML1995
Dr Penelope Taylor
Dr Helen Lucraft
Professor Stephen Proctor
Bone marrow examination in newly diagnosed Hodgkin's disease: Current practice in the United Kingdom1995
Professor Stephen Proctor
Current approaches to the management of herpes virus infection in bone marrow transplant and lymphoma patients1995
Professor Anne Dickinson
Professor Stephen Proctor
Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis1995
Dr Penelope Taylor
Dr Michael Reid
Dr Peter Hamilton
Professor Stephen Proctor
Dr Claire Bradford
et al.
De novo acute myeloid leukaemia in patients over 55-years-old: A population-based study of incidence, treatment and outcome1995
Professor Andrew Pearson
Professor Archibald Malcolm
Professor Stephen Proctor
Dr Peter Hamilton
Professor Andrew Cant
et al.
Human herpes virus-6 infection in marrow graft recipients: Role in pathogenesis of graft-versus-host disease1995
Professor Graham Jackson
Dr Anne Lennard
Dr Peter Hamilton
Professor Stephen Proctor
Low frequency of myelodysplasia after autologous bone marrow transplantation1995
Professor Andrew Pearson
Professor Stephen Proctor
Dr Peter Hamilton
Professor Andrew Cant
Professor Archibald Malcolm
et al.
Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host disease1995
Professor Stephen Proctor

Acute lymphoblastic leukaemia in adults: the case for a strategic shift in study approach

1994
Professor Liam Donaldson
Professor Stephen Proctor

Is it possible to catch leukaemia from a cat?

1994
Dr Anne Lennard
Dr Brian Angus
Professor Stephen Proctor

Prognostic Significance of Epstein Barr Virus Association in Hodgkins Disease

1994
Dr Penelope Taylor
Dr Michael Reid
Professor Stephen Proctor
Acute lymphoblastic leukaemia in the elderly1994
Professor Graham Jackson
Dr Penelope Taylor
Dr Anne Lennard
Professor Stephen Proctor
Autologous bone marrow transplantation in acute lymphoblastic leukaemia1994
Professor Graham Jackson
Dr Anne Lennard
Dr Penelope Taylor
Dr Peter Carey
Dr Brian Angus
et al.
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission1994
Dr John Taylor
Professor Stephen Proctor
Dr Peter Middleton
Characterization of non-concordance in the T-cell receptor γ chain genes at presentation and clinical relapse in acute lymphoblastic leukemia1994
Professor Anne Dickinson
Dr Peter Hamilton
Dr Penelope Taylor
Professor Graham Jackson
Professor Stephen Proctor
et al.
Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients1994
Professor Stephen Proctor
High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: The EBMT experience1994
Professor Anne Dickinson
Professor Graham Jackson
Professor Stephen Proctor
Monoclonal anti-TNF-α suppresses graft vs host disease reactions in an in vitro human skin model1994
Dr Linda Hogarth
Dr Michael Reid
Professor Stephen Proctor
Dr Peter Hamilton
Emeritus Professor Andy Hall
et al.
Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukaemia1994
Professor Graham Jackson
Dr Anne Lennard
Dr Penelope Taylor
Professor Stephen Proctor
Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease1994
Dr Mark Levasseur
Professor Graham Jackson
Dr Jennifer Kernahan
Professor Stephen Proctor
Dr Peter Middleton
et al.
Relapse of acute lymphoblastic leukaemia 14 years after presentation: use of molecular techniques to confirm true re-emergence1994
Dr Michael Reid
Professor Andrew Pearson
Professor Stephen Proctor
Dr Peter Hamilton
Emeritus Professor Andy Hall
et al.
The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia1994
Professor Stephen Proctor

Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing

1993
Professor Stephen Proctor
Dr Penelope Taylor
Dr Peter Hamilton
Acute lymphoblastic leukemia in adults: An unselected population-based study of 151 cases assessing the role of early transplantation versus standard maintenance (phase II study)1993
Dr Penelope Taylor
Dr Michael Reid
Dr Nicholas Bown
Dr Peter Hamilton
Professor Stephen Proctor
et al.
Acute myeloid leukemia in the over 55s: A population-based study of incidence, treatment and outcome1993
Dr Penelope Taylor
Professor Graham Jackson
Dr Anne Lennard
Dr Helen Lucraft
Professor Stephen Proctor
et al.
Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue1993
Professor Stephen Proctor
Dr Penelope Taylor
Classical staging of Hodgkin's disease is inappropriate for selecting patients for clinical trials of intensive therapy: The case for the objective use of prognostic factor information in addition to classical staging1993
Professor Stephen Proctor
Professor Tim Goodship
Immune complex glomerulonephritis, myasthenia gravis and
compensated hypothyroidism in a patient following allogeneic bone marrow transplantation
1993
Emeritus Professor Andy Hall
Dr Michael Reid
Professor Stephen Proctor
Invitro drug sensitivity testing in acute lymphoblastic-leukemia using the tetrazolium-based MTT assay1993
Dr Penelope Taylor
Dr Helen Lucraft
Professor Stephen Proctor
Patient education for self-referral and on-demand treatment for herpes zoster in lymphoma patients1993
Dr Anne Lennard
Dr Penelope Taylor
Professor Graham Jackson
Professor Stephen Proctor
Peripheral blood stem-cell transplantation versus non-cryopreserved autologous bone-marrow transplantation1993
Professor Andrew Pearson
Dr Peter Hamilton
Professor Stephen Proctor
Professor Archibald Malcolm
Prognostic importance of histological and immunopathological assessment of skin and rectal biopsies in patients with GVHD1993
Professor Stephen Proctor
Dr Penelope Taylor
Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation1993
Dr Penelope Taylor
Dr Michael Reid
Dr Peter Hamilton
Professor Stephen Proctor
Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome1992
Professor Sir John Burn
Professor Stephen Proctor
Hereditary haemorrhagic telangiectasia: a clinical analysis1992
Professor Anne Dickinson
Dr Anne Lennard
Dr Rosalind Cartner
Professor Stephen Proctor
Interleukin-2 induction of lymphokine-activated killer activity in the peripheral blood of an acute lymphoblastic leukaemia patient - case study1992
Dr Peter Middleton
Dr Penelope Taylor
Dr Michael Reid
Professor Graham Jackson
Professor Stephen Proctor
et al.
Alpha interferon gene deletions in adults, children and infants with acute lymphoblastic leukemia1991
Dr Peter Carey
Professor Stephen Proctor
Dr Peter Hamilton
Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation1991
Professor Anne Dickinson
Dr Peter Carey
Professor Stephen Proctor
Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model1991
Dr John Taylor
Professor Stephen Proctor
Dr Peter Middleton
Detection of T-cell receptor gamma chain V gene rearrangements using the polymerase chain reaction: application to the study of clonal disease cells in acute lymphoblastic leukemia1991
Dr Peter Carey
Professor Stephen Proctor
Dr Peter Hamilton
Ocular complications of bone marrow transplantation1991
Dr Anne Lennard
Professor Graham Jackson
Dr Peter Carey
Dr Peter Middleton
Professor Stephen Proctor
et al.
Secondary acute lymphoblastic leukaemia with 4:11 translocation following treatment for Hodgkin's disease1991
Professor Graham Jackson
Dr Andrea Clarke
Dr Penelope Taylor
Professor Anne Dickinson
Professor Stephen Proctor
et al.
Supernatant cell counts from long-term bone marrow culture correlate with the speed of engraftment following autologous bone marrow transplantation1991
Dr Peter Middleton
Dr Michael Reid
Professor Stephen Proctor
De novo Ph negative T-cell lymphoblastic leukaemia associated with BCR gene rearrangement1990
Dr Anne Lennard
Dr Peter Carey
Professor Graham Jackson
Professor Stephen Proctor
An effective oral combination in advanced relapsed Hodgkin’s disease prednisolone, etoposide, chlorambucil and CCNU1990
Professor Anne Dickinson
Dr Peter Carey
Professor Andrew Pearson
Professor Stephen Proctor
An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients1990
Professor Stephen Proctor
Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes: A multicenter study1990
Dr Brian Angus
Emeritus Professor Andy Hall
Professor Stephen Proctor
Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study1990
Professor Graham Jackson
Dr Jonathan Wallis
Dr Anne Lennard
Professor Stephen Proctor
Hydroxyurea-induced acute alveolitis in a Patient with chronic myeloid leukaemia1990
Emeritus Professor Andy Hall
Professor Stephen Proctor
Purification and characterization of a pi class glutathione S-transferase from human leukaemic cells1990
Professor Stephen Proctor
Professor Graham Jackson
Recombinant interferon alfa-2B in refractory idiopathic immune thrombocytopenia: Response1990
Professor Stephen Proctor
The potential use of thalidomide in the therapy of graft-versus-host disease: A review of clinical and laboratory information1990
Professor Andrew Pearson
Dr Michael Reid
Dr Jennifer Kernahan
Emeritus Professor Alan Craft
Dr Peter Hamilton
et al.
Virus infections in bone marrow transplant recipients: a three year prospective study1990
Professor Anne Dickinson
Professor Stephen Proctor
Detection of residual T-cells in T-cell depleted bone marrow: A comparison of immunofluorescence and limiting dilution culture techniques1989
Professor Andrew Pearson
Professor Archibald Malcolm
Professor Stephen Proctor
Dr Peter Hamilton
Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease1989
Professor Stephen Proctor
Professor Graham Jackson
Dr Peter Carey
Dr Roger Finney
Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon1989
Dr Anne Lennard
Professor Stephen Proctor
Dr Brian Angus
Dr Helen Lucraft
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease: A prospective study on behalf of the east of Scotland and Newcastle lymphoma group (ESNLG)1989
Emeritus Professor Andy Hall
Professor Stephen Proctor
Mechanisms of drug resistance in acute leukaemia1989
Emeritus Professor Andy Hall
Professor Craig Robson
Professor Stephen Proctor
Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line1989
Professor Graham Jackson
Dr Peter Carey
Professor Stephen Proctor
Severe renal toxicity due to intermediate-dose methotrexate1989
Emeritus Professor Andy Hall
Professor Craig Robson
Professor Stephen Proctor

Potentation of alkylating agents using indomethacin

1988
Professor Stephen Proctor
Professor Graham Jackson
Dr Peter Carey

Short-course alpha-interferon therapy in severe unresponsive immune thrombocytopenic purpura

1988
Professor Stephen Proctor
Dr Peter Hamilton
Dr Penelope Taylor
Dr Peter Carey
Dr Stuart Hargrave
et al.
A comparative study of combination chemotherapy versus marrow transplant in first remission in adult acute lymphoblastic leukaemia1988
Emeritus Professor Andy Hall
Professor Stephen Proctor
Case report: Hodgkin's disease involving the large bowel1988
Professor Andrew Pearson
Dr Peter Hamilton
Professor Stephen Proctor
Professor Archibald Malcolm
Class II antigen expression by keratinocytes and enterocytes: An early feature of graft-versus-host-disease1988
Professor Andrew Pearson
Dr Peter Hamilton
Professor Stephen Proctor
Professor Archibald Malcolm
Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation1988
Dr Peter Carey
Dr Michael Reid
Dr Peter Hamilton
Professor Andrew Pearson
Professor Stephen Proctor
et al.
HLA-DR, DP and DQ expression in GRAFT versus host disease (GVHD)1988
Professor Stephen Proctor
Professor Niall Cartlidge
Long-term survival of patients treated for central nervous system (CNS) lymphoma: Review of the literature and proposed clinical classification1988
Professor Andrew Pearson
Professor Stephen Proctor
Dr Peter Hamilton
Professor Archibald Malcolm
Lymphocyte subpopulation in early graft versus host disease (GVHD)1988
Professor Stephen Proctor
Dr Penelope Taylor
Prognostic index for clinical use in Hodgkins disease1988
Professor Anne Dickinson
Dr Michael Reid
Dr Peter Hamilton
Dr Jane Pearson
Professor Stephen Proctor
et al.
Skin explant culture as a model for cutaneous graft-versus-host disease in humans1988
Professor Anne Dickinson
Dr Peter Carey
Dr Michael Reid
Dr Peter Hamilton
Professor Andrew Pearson
et al.
Skin explant culture as a model for graft versus host disease1988
Professor Anne Dickinson
Dr Michael Reid
Professor Stephen Proctor
Suppression of human granulocyte-macrophage colony formation in vitro by natural killer cells1988
Emeritus Professor Andy Hall
Professor Stephen Proctor
Dr Peter Saunders

Increased platelet associated immunoglobulin in myelodysplastic syndromes

1987
Professor Stephen Proctor

Prognostic index for Hodgkins disease

1987
Emerita Professor Jane Calvert
Professor Stephen Proctor
Activation of B chronic lymphocytic leukaemia cells by Branhamella catarrhalis1987
Professor Stephen Proctor
Interaction of cimetidine with oral melphalan1987
Dr Mary Robinson
Dr Brian Angus
Professor Stephen Proctor
Lymphocyte depleted Hodgkins disease: A retrospective immunohistological study1987
Emeritus Professor Andy Hall
Professor Anne Dickinson
Professor Stephen Proctor
Measurement of in vitro drug sensitivity to human myeloma and chronic lymphocytic-leukemia1987
Professor Craig Robson
Emeritus Professor Andy Hall
Professor Stephen Proctor
Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity1987
Professor Stephen Proctor
Short course intermediate dose intravenous melphalan therapy in myeloma relation to early emergence of drug resistance (phase II study)1987
Dr Peter Carey
Professor Stephen Proctor
The Newcastle experience of lymphoproliferative disorders in hemophiliac patients with antibody to HIV1987
Professor Anne Dickinson
Professor Stephen Proctor
Defective in vitro immunoglobulin production in response to pokeweed mitogen in patients with Hodgkin's disease pretreatment and in remission1986
Professor Anne Dickinson
Dr Jennifer Kernahan
Dr Michael Reid
Professor Stephen Proctor
Professor Geoff Toms
et al.
Interferon responses of peripheral blood mononuclear cells from normal and leukaemic children1986
Emeritus Professor Andy Hall
Professor Stephen Proctor
Melphalan resistance in myeloma1986
Professor Philip Sloan
Kersi Fanibunda
Professor Stephen Proctor
Polymorphic reticulosis with oral lesions: A case report1986
Professor Stephen Proctor
Dr Peter Hamilton
Dr Michael Reid
Emeritus Professor Andy Hall
Progress in acute leukaemia in adults1986
Professor Stephen Proctor
Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands1986
Professor Stephen Proctor

Abnormal T lymphoproliferative disorder demonstrating in vitro suppressor and helper characteristics associated with Crohn's disease

1985
Professor Anne Dickinson
Dr Brian Shenton
Professor Stephen Proctor

Inhibition of natural killing and antibody-dependent cell-mediated cytotoxicity by the plasma protease inhibitor α2-macroglobulin (α2M) and α2M protease complexes

1985
Professor Anne Dickinson
Professor Peter Baylis
Dr Eric Young
Professor Stephen Proctor

Thyroid autoantibody synthesis by lymphocytes from different lymphoid organs: fractionation of B cells on density gradients

1985
Professor Stephen Proctor
Dr Roger Finney
Dr Michael Reid
Dr Peter Hamilton
Mehar Afroz Qureshi
et al.
Acute lymphoblastic leukaemia in adults in the northern region of England: A study of 75 cases1985
Professor Stephen Proctor
Deoxycoformycin in the treatment of leukemias and lymphomas1985
Professor Anne Dickinson
Professor Stephen Proctor
Dr Michael Reid
Emeritus Professor Alan Craft
Dr Jennifer Kernahan
et al.
Natural killer cell activity in childhood acute lymphoblastic leukaemia in remission1985
Professor Stephen Proctor
Recognition of a chronic relapsing form of Hodgkin's disease in a population of patients demonstrating no second tumours1985
Professor Stephen Proctor
Autoimmune haemolytic anaemia occurring in a patient with mycosis fungoides1984
Dr Anne Lennard
Professor Stephen Proctor
Chronic lymphocytic leukaemia terminating in acute myelofibrosis1984
Professor Stephen Proctor
Hyperviscosity syndrome in IgE myeloma1984
Professor Stephen Proctor
Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting1984
Professor Stephen Proctor
Staging laparotomy in Hodgkin's disease: Reply1984
Professor Stephen Proctor
The place of staging laparotomy in the management of Hodgkin's disease1984
Professor Stephen Proctor
Emeritus Professor Sir George Sir George Alberti
The relationship between human adipocyte and monocyte insulin binding1984
Dr Peter Jones
Professor Stephen Proctor
Professor Anne Dickinson

Altered immunology in haemophilia

1983
Professor Stephen Proctor
Professor Anne Dickinson
Cellular cyto-toxicity mechanisms in Hodgkins disease, non-Hodgkins lymphoma and renal transplants1983
Professor Peter Baylis
Professor Stephen Proctor
Enrichment and depletion of thyroglobulin autoantibody synthesizing lymphocytes1983
Professor Anne Dickinson
Professor Peter Baylis
Professor Stephen Proctor
Dr David Crawford
Enrichment and depletion of thyroglobulin autoantibody-synthesizing lymphocytes1983
Dr Margaret Jackson
Professor Stephen Proctor
Hypothermia during chemotherapy for Hodgkin's disease1983
Dr Peter Saunders
Professor Stephen Proctor
Lymphoplasmacytoid lymphoma, associated paraproteinaemia and haemolytic anaemia: A report of 2 cases and review of the literature1983
Professor Stephen Proctor
Patterns of acute phase reactant proteins (APRS) and immune-complexes (IC) in lymphomas compared with other systemic diseases1983
Dr Hilary Wastell
Professor Stephen Proctor
Relationship of lymphocyte anisocytosis in chronic lymphatic leukaemia to mouse red cell rosetting capacity and clinical stage1983
Professor Anne Dickinson
Professor Stephen Proctor
T cell subpopulations in CLL: Methods of T cell enrichment artificially alter proportions of OKT4 and OKT8 positive cells1983
Professor Anne Dickinson
Professor Archibald Malcolm
Professor Stephen Proctor
Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes .1. lymphocyte markers and response to pokeweed mitogen1983
Professor Stephen Proctor
Professor Anne Dickinson
Atypical T lymphoproliferative disorder demonstrating in vitro suppressor and helper characteristics1982
Professor Anne Dickinson
Professor Archibald Malcolm
Professor Stephen Proctor
Autoantibody synthesis by thyroid lymphocytes1982
Professor Stephen Proctor
Erythema nodosum and Hodgkin's disease1982
Dr Michael Reid
Professor Stephen Proctor
Failure of FAB classification to predict relapse-free survival in acute leukaemia1982
Professor Anne Dickinson
Professor Stephen Proctor
Interferon production and NK cell activity of peripheral blood lymphocytes from normal children and adults and patients with acute lymphoblastic leukemias
1982
Professor Stephen Proctor
Professor Anne Dickinson
NK and ADCC in Hodgkins disease, non-Hodgkins lymphoma and renal transplantation1982
Professor Stephen Proctor
Dr Jennifer Kernahan
Dr Penelope Taylor

Depression as componet of post-cranial irradiation somnolence syndrome

1981
Dr John Owen
Professor Stephen Proctor
Dr Peter Hamilton
Multiple myeloma: Radiology or bone scanning?1981
Professor Stephen Proctor
Professor Anne Dickinson
Terminal deoxynucleotidyl transferase activity in childhood and adult acute lymphoblastic leukaemia1981
Professor Stephen Proctor
Dr Roger Finney
Treatment of adult lymphoblastic leukaemia using cyclical chemotherapy with three combinations of four drugs (COAP, POMP, TRAP schedule)1981
Professor Stephen Proctor
Professor Niall Cartlidge
Treatment of malignant lymphoma with central nervous system involvement1981
Professor Stephen Proctor
Dr Peter Hamilton
Acute monoblastic leukaemia with skin infiltration responding to bleomycin and vincristine1980
Professor Stephen Proctor
Anti-endotoxin (anti-lipid-A) antibodies1980
Professor Stephen Proctor
Dr Peter Jones
Increased platelet aggregation induced by glucagon administration1980
Professor Stephen Proctor
Professor Niall Cartlidge
Intracranial disease in non-Hodgkin's lymphoma1980
Professor Stephen Proctor
Dr Michael Reid
Levamisole in the treatment of cyclical neutropenia1979
Professor Stephen Proctor
Cerebral involvement in multiple myeloma: case report1978
Professor Stephen Proctor
Nephrocalcinosis: another cause of renal erythrocytosis1978
Professor Stephen Proctor
Malignant myelosclerosis: Myeloproliferative disorder or leukemia?1977
Professor Stephen Proctor
Anisocytosis and the C-1000 Channelyzer in macrocytic anaemia1976
Professor Stephen Proctor
Imuran-induced macrocytosis and splenectomy following renal transplantation1976